govt.chinadaily.com.cn

News and Policies

Daxing Biotech Firm Advances Innovative Therapy Against Liver Cancer

Updated: Oct 26, 2025 Print
Share - WeChat

Fighting liver cancer with groundbreaking innovation! Beijing Gene Key Life Technology introduces GKL-006 injection, harnessing the power of iNKT cells to combat this global health threat.

Pioneering cell therapy at Daxing Biomedical Industrial Base, Gene Key's expertise in cell biology and immunology shines through.

With GKL-006 in clinical trials, they're spearheading a new era in cancer treatment.

Copyright©2026 China Daily. All rights reserved.

京ICP备13028878号-6

京公网安 京公网安备 11010502032503号